The patient controlled injectors global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Patient Controlled Injectors Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The patient-controlled injectors market size has grown rapidly in recent years. It will grow from $4.01 billion in 2023 to $4.51 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to growth in home healthcare, expansion of healthcare infrastructure, increasing cases of diabetes, increased prevalence of infectious diseases, and increasing focus on personalized medicine.
The patient-controlled injectors market size is expected to see rapid growth in the next few years. It will grow to $7.32 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to a rising aging population, rising incidence of chronic respiratory diseases, increasing prevalence of chronic diseases, increasing cancer cases, and increasing autoimmune disorders prevalence. Major trends in the forecast period include technological advancements, integration of artificial intelligence, telemedicine, remote monitoring, advancements in portable and wearable devices, and focus on minimally invasive procedures.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/patient-controlled-injectors-global-market-report
Scope Of Patient Controlled Injectors Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Patient Controlled Injectors Market Overview
Market Drivers –
The increase in the prevalence of chronic diseases is expected to propel the growth of the patient-controlled injectors market going forward. Chronic illness is a long-term health condition that usually lasts three months or longer and may worsen over time. The rise in chronic illness is due to factors such as the aging population, the obesity epidemic, socioeconomic factors, and environmental exposures. Chronic diseases use patient-controlled injectors to allow patients to self-administer medications with precision, ease, and on a schedule that aligns with their treatment plans. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based medicine library, the number of people aged 50 and above who suffer from one or more chronic illnesses is expected to increase by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the increase in the prevalence of chronic diseases is expected to drive the growth of the patient-controlled injectors market.
Market Trends –
Major companies operating in the patient-controlled injectors market are developing innovative products, such as ready-to-use syringes, to serve customers with advanced features better. Ready-to-use syringes are prefilled, sterilized syringes with a predetermined dose of medication, eliminating the need for manual preparation and reducing the risk of contamination and dosing errors. For instance, in October 2022, Ypsomed AG, a Switzerland-based medical equipment manufacturer, launched a new autoinjector platform designed for liquid pharmaceuticals with capacities ranging from 1.5 to 5.5 ml. This innovative device features an ergonomic design for ease of use, ensuring patient comfort during injections. It includes advanced safety mechanisms to prevent accidental needle sticks and provides visual and audible feedback to confirm the successful delivery of the medication. The autoinjector is also compatible with various viscosities, making it versatile for therapeutic applications.
The patient controlled injectors market covered in this report is segmented –
1) By Product: Electronic Wearable Injector, Mechanical Wearable Injector, Infusion Pumps
2) By Application: Cancer Treatment, Auto-Immune Treatment, Blood Disorder Treatment, Other Application
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies
Get an inside scoop of the patient controlled injectors market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16759&type=smp
Regional Insights –
North America was the largest region in the patient controlled injectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient controlled injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical
Table of Contents
1. Executive Summary
2. Patient Controlled Injectors Market Report Structure
3. Patient Controlled Injectors Market Trends And Strategies
4. Patient Controlled Injectors Market – Macro Economic Scenario
5. Global Patient Controlled Injectors Market Size and Growth
.
.
.
32. Global Patient Controlled Injectors Market Competitive Benchmarking
33. Global Patient Controlled Injectors Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Patient Controlled Injectors Market
35. Patient Controlled Injectors Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
